Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05118802 · ClinicalTrials.gov registry record
Measuring the Impact of MANNA s Medically Tailored Meal Program in Patients With a Non-terminal Cancer Diagnosis
A clinical trial, sponsored by Thomas Jefferson University.
- Completed
- Registry status
- 46
- Enrollment target
NCT05118802: Completed study, sponsored by Thomas Jefferson University.
NCT05118802 is a clinical trial that has completed, run by Thomas Jefferson University. The registered enrollment target is 46 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05118802 has completed, sponsored by Thomas Jefferson University.
- COMPLETED
- Registry status
- 46 participants
- Enrollment target
Study Summary
This study identifies patient-important outcome measures and develops a survey that assesses the impact of nutritional interventions among cancer patients. Currently, data on the impact of medically tailored meals on outcomes that are meaningful to patients, providers, and payers are limited. For this reason, access to medically tailored meals as a covered benefit for cancer patients is limited. Thus, there is a need to explore the efficacy of nutritional interventions among this population. This study identifies outcome measures for nutritional interventions that are meaningful to patients and providers.
Primary Outcome
Reported as average time required to complete each assessment.
Interventions
- OTHER Survey Administration
- OTHER Interview
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 46 participants |
| Start Date | 2021-08-11 |
| Est. Completion | 2023-03-03 |
What the finished NCT05118802 record still lists
NCT05118802 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 46 participants, a relatively small participant target.
The record links to 0 conditions, and to 2 interventions - of which Survey Administration is the first listed.
NCT05118802 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05118802 about?
NCT05118802 is a clinical study titled "Measuring the Impact of MANNA s Medically Tailored Meal Program in Patients With a Non-terminal Cancer Diagnosis". This study identifies patient-important outcome measures and develops a survey that assesses the impact of nutritional interventions among cancer patients. Currently, data on the impact of medically tailored meals on outcomes that are meaningful to patients, providers, and payers are limited. For th...
What is the current status of trial NCT05118802?
This trial is currently completed. The enrollment target is 46 participants. The study started on 2021-08-11. Estimated completion is 2023-03-03.
What interventions are being tested in trial NCT05118802?
The interventions under investigation include: Survey Administration (OTHER), Interview (OTHER).
Who is sponsoring clinical trial NCT05118802?
This trial is sponsored by Thomas Jefferson University, which has 292 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01890590 · 46 participants · NA
A Phase II Study of Cyberknife Radiosurgery for Renal Cell Carcinoma
- NCT03191149 · 46 participants · Phase 2
Testing Osimertinib as a Treatment for Lung Cancers With an EGFR Exon 20 Change
- NCT03510208 · 46 participants · Phase 1
Panitumumab-IRDye800 in Diagnosing Participants With Malignant Glioma Undergoing Surgery
- NCT04048278 · 46 participants · Early Phase 1
Lidocaine Infusion in Pancreatic Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI